Laurence Legrand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laurence Legrand has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
- Catherine Oppenheim
Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-Brain, 75014 Paris, France
29 shared publications - Olivier Naggara
Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMABRAIN, GHU‐Paris Psychiatrie et Neurosciences, Centre Hospitalier Sainte‐Anne Université Paris Cité Paris France
21 shared publications - Jean Francois Meder
From the Departments of Neuroradiology (R.A.C., M.E., W.B.H., G.B., C.R.R., D.T., J.-F.M., C.O., O.N.) and Neurology (C.L.), Centre Hospitalier Sainte-Anne, GHU Paris Psychiatrie & Neurosciences, Paris University, INSERM UMR 1266, Paris, France
20 shared publications - Guillaume Turc
Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, France (N.C., J.B., W.B.H., D.S., G.T.).
17 shared publications - Jean-Claude Baron
Institut de Psychiatrie et Neurosciences de Paris, Inserm U1266, Université Paris Cité, Paris, France
14 shared publications Jean-Louis Mas
From the Departments of Neurology (P.S., G.T., J.-L.M., J.-C.B.) and Radiology (L.L., O.N., C.O.), Hôpital Sainte-Anne, Paris, France; Université Paris Descartes, Sorbonne Paris Citeé, INSERM UMR S894, DHU Neurovasc, France (P.S., G.T., L.L., O.N., J.-L.M., C.O., J.-C.B.); Department of Clinical Neurosciences, University of Cambridge, United Kingdom (R.H.); and Service de Radiologie, Hoôpital Foch, Suresnes, France (M.T.).
10 shared publications
Latest Publications
- 7 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Hypersignaux vasculaires en FLAIR dans l'accident ischémique cérébral aigu : physiopathologie et valeur pronostique en IRM
L'imagerie cérébrale joue un rôle central dans la prise en charge de l'AVC ischémique aigu. En IRM, la séquence Fluid-Attenuated Inversion Recovery (FLAIR) permet de dater l'ischémie et d'écarter un diagnostic différentiel. En FLAIR, les artères intracrâniennes ne sont pas visibles en conditions normales (perte de signal liée au mouvement du sang). En cas d'occlusion artérielle, des hypersignaux vasculaires (FLAIR vascular hyperintensities [FVH]) sont visualisés, traduisant un ralentissement du flux dans les collatérales leptoméningées. Bien qu'étudiées depuis deux décennies, la physiopathologie et la valeur pronostique des FVH restent controversées. Cette thèse a pour objectif d'améliorer les connaissances sur les FVH, notamment de mieux comprendre leur lien avec la circulation collatérale et leur valeur pronostique à l'ère de la thrombectomie, et de comparer les méthodes pour les évaluer. Après avoir montré que le mismatch FVH'DWI (diffusion-weighted imaging), i.e. la présence de FVH au-delà de la lésion en diffusion, était associé à une large pénombre et à un bénéfice de la thrombolyse intraveineuse, nous avons étudié sa valeur pronostique pour identifier les patients bénéficiant d'une recanalisation par thrombectomie. Dans une cohorte multicentrique de 100 patients, nous avons montré que la recanalisation était associée à une meilleure évolution clinique chez les patients ayant un FVH'DWI mismatch (OR: 15.05, 95%CI 3.12'72.61, P<0.001), mais pas chez ceux sans FVH'DWI mismatch (OR: 0.83, 95%CI 0.15'4.64, P=0.84). Nous avons ensuite testé l'hypothèse selon laquelle l'extension des FVH au-delà de la lésion en diffusion (i.e. du mismatch FVH'DWI) est un meilleur substitut de la collatéralité que l'extension de tous les FVH (i.e. en aveugle de la diffusion), avec une échelle semi-quantitative basée sur le score ASPECTS (Alberta Stroke Program Early Computed Tomography Score). Dans une cohorte multicentrique de 209 patients avec cartographies des collatérales issues des données d'IRM de perfusion, nous avons montré que l'étendue de tous les FVH était similaire chez les patients ayant des bonnes ou mauvaises collatérales (médiane [IQR] : 5 [4-5.5] versus 5 [4-5], P=0.76), alors que l'étendue du mismatch FVH'DWI était plus importante chez les patients ayant des bonnes collatérales que chez ceux ayant des mauvaises collatérales (4 [3-5] versus 2 [0-2.75], P<0.001). Ainsi, plus les FVH étaient nombreux au-delà de la lésion en diffusion, meilleures était la collatéralité. Afin de faciliter le transfert clinique, nous avons ensuite testé un score simplifié d'extension du mismatch FVH'DWI (4 classes). La corrélation avec la qualité de la collatéralité était similaire à celle selon ASPECTS, avec une bonne reproductibilité intra et interobservateur (coefficients de corrélation intraclasse: 0.91 [0.88-0.93] et 0.86 [0.81-0.89], respectivement). Enfin, nous avons étudié l'influence des paramètres techniques en IRM sur la visualisation des FVH sur une base de données issues d'appareils IRM de différents constructeurs et confirmé les résultats publiés sur fantôme: plus le temps d'écho est bas et plus l'angle de bascule est élevé, meilleure est la visualisation des FVH. Nos résultats participent à une meilleure compréhension des FVH, qui, analysés conjointement à l'imagerie de diffusion, reflètent la collatéralité en cas d'occlusion artérielle intracrânienne. Le mismatch FVH'DWI est un biomarqueur simple et visuel ne nécessitant ni injection de produit de contraste, ni séquence supplémentaire. Il est associé à un bénéfice de la recanalisation, et son extension est associée à la qualité de la collatéralité. Une standardisation des paramètres d'acquisition de la séquence FLAIR et des méthodes d'évaluation des FVH reste nécessaire pour de futures études multicentriques utilisant les FVH comme biomarqueur des collatérales.
- 7 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Hypersignaux vasculaires en FLAIR dans l'accident ischémique cérébral aigu : physiopathologie et valeur pronostique en IRM
L'imagerie cérébrale joue un rôle central dans la prise en charge de l'AVC ischémique aigu. En IRM, la séquence Fluid-Attenuated Inversion Recovery (FLAIR) permet de dater l'ischémie et d'écarter un diagnostic différentiel. En FLAIR, les artères intracrâniennes ne sont pas visibles en conditions normales (perte de signal liée au mouvement du sang). En cas d'occlusion artérielle, des hypersignaux vasculaires (FLAIR vascular hyperintensities [FVH]) sont visualisés, traduisant un ralentissement du flux dans les collatérales leptoméningées. Bien qu'étudiées depuis deux décennies, la physiopathologie et la valeur pronostique des FVH restent controversées. Cette thèse a pour objectif d'améliorer les connaissances sur les FVH, notamment de mieux comprendre leur lien avec la circulation collatérale et leur valeur pronostique à l'ère de la thrombectomie, et de comparer les méthodes pour les évaluer. Après avoir montré que le mismatch FVH'DWI (diffusion-weighted imaging), i.e. la présence de FVH au-delà de la lésion en diffusion, était associé à une large pénombre et à un bénéfice de la thrombolyse intraveineuse, nous avons étudié sa valeur pronostique pour identifier les patients bénéficiant d'une recanalisation par thrombectomie. Dans une cohorte multicentrique de 100 patients, nous avons montré que la recanalisation était associée à une meilleure évolution clinique chez les patients ayant un FVH'DWI mismatch (OR: 15.05, 95%CI 3.12'72.61, P<0.001), mais pas chez ceux sans FVH'DWI mismatch (OR: 0.83, 95%CI 0.15'4.64, P=0.84). Nous avons ensuite testé l'hypothèse selon laquelle l'extension des FVH au-delà de la lésion en diffusion (i.e. du mismatch FVH'DWI) est un meilleur substitut de la collatéralité que l'extension de tous les FVH (i.e. en aveugle de la diffusion), avec une échelle semi-quantitative basée sur le score ASPECTS (Alberta Stroke Program Early Computed Tomography Score). Dans une cohorte multicentrique de 209 patients avec cartographies des collatérales issues des données d'IRM de perfusion, nous avons montré que l'étendue de tous les FVH était similaire chez les patients ayant des bonnes ou mauvaises collatérales (médiane [IQR] : 5 [4-5.5] versus 5 [4-5], P=0.76), alors que l'étendue du mismatch FVH'DWI était plus importante chez les patients ayant des bonnes collatérales que chez ceux ayant des mauvaises collatérales (4 [3-5] versus 2 [0-2.75], P<0.001). Ainsi, plus les FVH étaient nombreux au-delà de la lésion en diffusion, meilleures était la collatéralité. Afin de faciliter le transfert clinique, nous avons ensuite testé un score simplifié d'extension du mismatch FVH'DWI (4 classes). La corrélation avec la qualité de la collatéralité était similaire à celle selon ASPECTS, avec une bonne reproductibilité intra et interobservateur (coefficients de corrélation intraclasse: 0.91 [0.88-0.93] et 0.86 [0.81-0.89], respectivement). Enfin, nous avons étudié l'influence des paramètres techniques en IRM sur la visualisation des FVH sur une base de données issues d'appareils IRM de différents constructeurs et confirmé les résultats publiés sur fantôme: plus le temps d'écho est bas et plus l'angle de bascule est élevé, meilleure est la visualisation des FVH. Nos résultats participent à une meilleure compréhension des FVH, qui, analysés conjointement à l'imagerie de diffusion, reflètent la collatéralité en cas d'occlusion artérielle intracrânienne. Le mismatch FVH'DWI est un biomarqueur simple et visuel ne nécessitant ni injection de produit de contraste, ni séquence supplémentaire. Il est associé à un bénéfice de la recanalisation, et son extension est associée à la qualité de la collatéralité. Une standardisation des paramètres d'acquisition de la séquence FLAIR et des méthodes d'évaluation des FVH reste nécessaire pour de futures études multicentriques utilisant les FVH comme biomarqueur des collatérales.
- Open Access
- 15 December 2022
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (1) , 26-32
FLAIR Vascular Hyperintensities as a Surrogate of Collaterals in Acute Stroke: DWI Matters
BACKGROUND AND PURPOSE: FLAIR vascular hyperintensities are thought to represent leptomeningeal collaterals in acute ischemic stroke. However, whether all–FLAIR vascular hyperintensities or FLAIR vascular hyperintensities–DWI mismatch, ie, FLAIR vascular hyperintensities beyond the DWI lesion, best reflects collaterals remains debated. We aimed to compare the value of FLAIR vascular hyperintensities–DWI mismatch versus all–FLAIR vascular hyperintensities for collateral assessment using PWI-derived collateral flow maps as a reference. MATERIALS AND METHODS: We retrospectively reviewed the registries of 6 large stroke centers and included all patients with acute stroke with anterior circulation large-vessel occlusion who underwent MR imaging with PWI before thrombectomy. Collateral status was graded from 1 to 4 on PWI-derived collateral flow maps and dichotomized into good (grades 3–4) and poor (grades 1–2). The extent of all–FLAIR vascular hyperintensities and FLAIR vascular hyperintensities–DWI mismatch was assessed on the 7 cortical ASPECTS regions, ranging from 0 (absence) to 7 (extensive), and associations with good collaterals were compared using receiver operating characteristic curves. RESULTS: Of the 209 included patients, 133 (64%) and 76 (36%) had good and poor collaterals, respectively. All–FLAIR vascular hyperintensity extent was similar between collateral groups (P = .76). Conversely, FLAIR vascular hyperintensities–DWI mismatch extent was significantly higher in patients with good compared with poor collaterals (P < .001). The area under the curve was 0.80 (95% CI, 0.74–0.87) for FLAIR vascular hyperintensities–DWI mismatch and 0.52 (95% CI, 0.44–0.60) for all–FLAIR vascular hyperintensities (P < .001 for the comparison), to predict good collaterals. Variables independently associated with good collaterals were smaller DWI lesion volume (P < .001) and larger FLAIR vascular hyperintensities–DWI mismatch (P = .02). CONCLUSIONS: In acute ischemic stroke with large-vessel occlusion, the extent of FLAIR vascular hyperintensities does not reliably reflect collateral status unless one accounts for DWI.
- 15 December 2022
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (1) , 26-32
Open AccessFLAIR Vascular Hyperintensities as a Surrogate of Collaterals in Acute Stroke: DWI Matters
BACKGROUND AND PURPOSE: FLAIR vascular hyperintensities are thought to represent leptomeningeal collaterals in acute ischemic stroke. However, whether all–FLAIR vascular hyperintensities or FLAIR vascular hyperintensities–DWI mismatch, ie, FLAIR vascular hyperintensities beyond the DWI lesion, best reflects collaterals remains debated. We aimed to compare the value of FLAIR vascular hyperintensities–DWI mismatch versus all–FLAIR vascular hyperintensities for collateral assessment using PWI-derived collateral flow maps as a reference. MATERIALS AND METHODS: We retrospectively reviewed the registries of 6 large stroke centers and included all patients with acute stroke with anterior circulation large-vessel occlusion who underwent MR imaging with PWI before thrombectomy. Collateral status was graded from 1 to 4 on PWI-derived collateral flow maps and dichotomized into good (grades 3–4) and poor (grades 1–2). The extent of all–FLAIR vascular hyperintensities and FLAIR vascular hyperintensities–DWI mismatch was assessed on the 7 cortical ASPECTS regions, ranging from 0 (absence) to 7 (extensive), and associations with good collaterals were compared using receiver operating characteristic curves. RESULTS: Of the 209 included patients, 133 (64%) and 76 (36%) had good and poor collaterals, respectively. All–FLAIR vascular hyperintensity extent was similar between collateral groups (P = .76). Conversely, FLAIR vascular hyperintensities–DWI mismatch extent was significantly higher in patients with good compared with poor collaterals (P < .001). The area under the curve was 0.80 (95% CI, 0.74–0.87) for FLAIR vascular hyperintensities–DWI mismatch and 0.52 (95% CI, 0.44–0.60) for all–FLAIR vascular hyperintensities (P < .001 for the comparison), to predict good collaterals. Variables independently associated with good collaterals were smaller DWI lesion volume (P < .001) and larger FLAIR vascular hyperintensities–DWI mismatch (P = .02). CONCLUSIONS: In acute ischemic stroke with large-vessel occlusion, the extent of FLAIR vascular hyperintensities does not reliably reflect collateral status unless one accounts for DWI.
- 6 September 2022
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 160 (1) , 127-136
Meningioma in patients exposed to progestin drugs: results from a real-life screening program
Purpose To report the results of systematic meningioma screening program implemented by French authorities in patients exposed to progestin therapies (cyproterone (CPA), nomegestrol (NA), and chlormadinone (CMA) acetate). Methods We conducted a prospective monocentric study on patients who, between September 2018 and April 2021, underwent standardized MRI (injection of gadolinium, then a T2 axial FLAIR and a 3D-T1 gradient-echo sequence) for meningioma screening. Results Of the 210 included patients, 15 (7.1%) had at least one meningioma; seven (7/15, 47%) had multiple meningiomas. Meningiomas were more frequent in older patients and after exposure to CPA (13/103, 13%) compared to NA (1/22, 4%) or CMA (1/85, 1%; P = 0.005). After CPA exposure, meningiomas were associated with longer treatment duration (median = 20 vs 7 years, P = 0.001) and higher cumulative dose (median = 91 g vs. 62 g, P = 0.014). Similarly, their multiplicity was associated with higher dose of CPA (median = 244 g vs 61 g, P = 0.027). Most meningiomas were ≤ 1 cm3 (44/58, 76%) and were convexity meningiomas (36/58, 62%). At diagnosis, patients were non-symptomatic, and all were managed conservatively. Among 14 patients with meningioma who stopped progestin exposure, meningioma burden decreased in 11 (79%) cases with no case of progression during MR follow-up. Conclusion Systematic MR screening in progestin-exposed patients uncovers small and multiple meningiomas, which can be managed conservatively, decreasing in size after progestin discontinuation. The high rate of meningiomas after CPA exposure reinforces the need for systematic screening. For NA and CMA, further studies are needed to identify patients most likely to benefit from screening.
- 6 September 2022
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 160 (1) , 127-136
Meningioma in patients exposed to progestin drugs: results from a real-life screening program
Purpose To report the results of systematic meningioma screening program implemented by French authorities in patients exposed to progestin therapies (cyproterone (CPA), nomegestrol (NA), and chlormadinone (CMA) acetate). Methods We conducted a prospective monocentric study on patients who, between September 2018 and April 2021, underwent standardized MRI (injection of gadolinium, then a T2 axial FLAIR and a 3D-T1 gradient-echo sequence) for meningioma screening. Results Of the 210 included patients, 15 (7.1%) had at least one meningioma; seven (7/15, 47%) had multiple meningiomas. Meningiomas were more frequent in older patients and after exposure to CPA (13/103, 13%) compared to NA (1/22, 4%) or CMA (1/85, 1%; P = 0.005). After CPA exposure, meningiomas were associated with longer treatment duration (median = 20 vs 7 years, P = 0.001) and higher cumulative dose (median = 91 g vs. 62 g, P = 0.014). Similarly, their multiplicity was associated with higher dose of CPA (median = 244 g vs 61 g, P = 0.027). Most meningiomas were ≤ 1 cm3 (44/58, 76%) and were convexity meningiomas (36/58, 62%). At diagnosis, patients were non-symptomatic, and all were managed conservatively. Among 14 patients with meningioma who stopped progestin exposure, meningioma burden decreased in 11 (79%) cases with no case of progression during MR follow-up. Conclusion Systematic MR screening in progestin-exposed patients uncovers small and multiple meningiomas, which can be managed conservatively, decreasing in size after progestin discontinuation. The high rate of meningiomas after CPA exposure reinforces the need for systematic screening. For NA and CMA, further studies are needed to identify patients most likely to benefit from screening.
- 1 September 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (9) , 2809-2817
TAGE Score for Symptomatic Intracranial Hemorrhage Prediction After Successful Endovascular Treatment in Acute Ischemic Stroke
Background: Determine if early venous filling (EVF) after complete successful recanalization with mechanical thrombectomy in acute ischemic stroke is an independent predictor of symptomatic intracranial hemorrhage (sICH) and integrate EVF into a risk score for sICH prediction. Methods: Consecutive patients with anterior acute ischemic stroke treated by mechanical thrombectomy issued from patients enrolled in the THRACE trial (Thrombectomie des Artères Cérébrales) and from 2 prospective registries were included and divided into a derivation (Center I; n=402) and validation cohorts (THRACE and center 2; n=507). EVF was evaluated by 2 blinded readers. sICH was defined according to the modified European cooperative acute stroke study II. Clinical and radiological data were analyzed in the derivation cohort (C1) to identify independent predictors of sICH and construct a predictive score test on the validation cohort (THRACE + C2). Results: Symptomatic ICH rate was similar between the two cohorts (9.9% and 8.9% respectively, P =0.9). Time from onset-to-successful recanalization >270 minutes (odds ratio [OR], 7.8 [95% CI, 2.5–24]), Alberta Stroke Program Early CT Score (≤5 [OR, 2.49 (95% CI, 1.8–8.1) or 6–7 [OR, 1.15 (95% CI, 1.03–4.46)]), glucose blood level >7 mmol/L (OR, 2.92 [95% CI, 1.26–6.7]), and EVF presence (OR, 11.9 [95% CI, 3.8–37.5]) were independent predictors of sICH and constituted the Time–Alberta Stroke Program Early CT–Glycemia–EVF score. Time–Alberta Stroke Program Early CT–Glycemia–EVF score was associated with an increased risk of sICH in the derivation cohort (OR increase per unit, 1.99 [95% CI, 1.53–2.59]; P <0.001) with area under the curve, 0.832 [95% CI, 0.767–0.898]. The score had good performance in the validation cohort (area under the curve, 0.801 [95% CI, 0.69–0.91]). Conclusions: Time–Alberta Stroke Program Early CT–Glycemia–EVF score is a simple tool with readily available clinical variables with good performances for sICH prediction after mechanical thrombectomy. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01062698.
- 1 September 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (9) , 2809-2817
TAGE Score for Symptomatic Intracranial Hemorrhage Prediction After Successful Endovascular Treatment in Acute Ischemic Stroke
Background: Determine if early venous filling (EVF) after complete successful recanalization with mechanical thrombectomy in acute ischemic stroke is an independent predictor of symptomatic intracranial hemorrhage (sICH) and integrate EVF into a risk score for sICH prediction. Methods: Consecutive patients with anterior acute ischemic stroke treated by mechanical thrombectomy issued from patients enrolled in the THRACE trial (Thrombectomie des Artères Cérébrales) and from 2 prospective registries were included and divided into a derivation (Center I; n=402) and validation cohorts (THRACE and center 2; n=507). EVF was evaluated by 2 blinded readers. sICH was defined according to the modified European cooperative acute stroke study II. Clinical and radiological data were analyzed in the derivation cohort (C1) to identify independent predictors of sICH and construct a predictive score test on the validation cohort (THRACE + C2). Results: Symptomatic ICH rate was similar between the two cohorts (9.9% and 8.9% respectively, P =0.9). Time from onset-to-successful recanalization >270 minutes (odds ratio [OR], 7.8 [95% CI, 2.5–24]), Alberta Stroke Program Early CT Score (≤5 [OR, 2.49 (95% CI, 1.8–8.1) or 6–7 [OR, 1.15 (95% CI, 1.03–4.46)]), glucose blood level >7 mmol/L (OR, 2.92 [95% CI, 1.26–6.7]), and EVF presence (OR, 11.9 [95% CI, 3.8–37.5]) were independent predictors of sICH and constituted the Time–Alberta Stroke Program Early CT–Glycemia–EVF score. Time–Alberta Stroke Program Early CT–Glycemia–EVF score was associated with an increased risk of sICH in the derivation cohort (OR increase per unit, 1.99 [95% CI, 1.53–2.59]; P <0.001) with area under the curve, 0.832 [95% CI, 0.767–0.898]. The score had good performance in the validation cohort (area under the curve, 0.801 [95% CI, 0.69–0.91]). Conclusions: Time–Alberta Stroke Program Early CT–Glycemia–EVF score is a simple tool with readily available clinical variables with good performances for sICH prediction after mechanical thrombectomy. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01062698.
- 1 April 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (1) , 153-159
Synthetic FLAIR as a Substitute for FLAIR Sequence in Acute Ischemic Stroke
Synthetic fluid-attenuated inversion recovery (FLAIR) generated with deep learning is as accurate as a real FLAIR sequence for the identification of early stroke. Background In acute ischemic stroke (AIS), fluid-attenuated inversion recovery (FLAIR) is used for treatment decisions when onset time is unknown. Synthetic FLAIR could be generated with deep learn...
- 1 April 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (1) , 153-159
Synthetic FLAIR as a Substitute for FLAIR Sequence in Acute Ischemic Stroke
Synthetic fluid-attenuated inversion recovery (FLAIR) generated with deep learning is as accurate as a real FLAIR sequence for the identification of early stroke. Background In acute ischemic stroke (AIS), fluid-attenuated inversion recovery (FLAIR) is used for treatment decisions when onset time is unknown. Synthetic FLAIR could be generated with deep learn...
- 12 November 2020
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (1) , 42-48
Clot Burden Score and Collateral Status and Their Impact on Functional Outcome in Acute Ischemic Stroke
BACKGROUND AND PURPOSE: Collateral status and thrombus length have been independently associated with functional outcome in patients with acute ischemic stroke. It has been suggested that thrombus length would influence functional outcome via interaction with the collateral circulation. We investigated the individual and combined effects of thrombus length assessed by the clot burden score and collateral status assessed by a FLAIR vascular hyperintensity–ASPECTS rating system on functional outcome (mRS). MATERIALS AND METHODS: Patients with anterior circulation acute ischemic stroke due to large-vessel occlusion from the ASTER and THRACE trials treated with endovascular thrombectomy were pooled. The clot burden score and FLAIR vascular hyperintensity score were determined on MR imaging obtained before endovascular thrombectomy. Favorable outcome was defined as an mRS score of 0–2 at 90 days. Association of the clot burden score and the FLAIR vascular hyperintensity score with favorable outcome (individual effect and interaction) was examined using logistic regression models. RESULTS: Of the 326 patients treated by endovascular thrombectomy with both the clot burden score and FLAIR vascular hyperintensity assessment, favorable outcome was observed in 165 (51%). The rate of favorable outcome increased with clot burden score (smaller clots) and FLAIR vascular hyperintensity (better collaterals) values. The association between clot burden score and functional outcome was significantly modified by the FLAIR vascular hyperintensity score, and this association was stronger in patients with good collaterals, with an adjusted OR = 6.15 (95% CI, 1.03–36.81). CONCLUSIONS: The association between the clot burden score and functional outcome varied for different collateral scores. The FLAIR vascular hyperintensity score might be a valuable prognostic factor, especially when contrast-based vascular imaging is not available.
- 12 November 2020
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (1) , 42-48
Clot Burden Score and Collateral Status and Their Impact on Functional Outcome in Acute Ischemic Stroke
BACKGROUND AND PURPOSE: Collateral status and thrombus length have been independently associated with functional outcome in patients with acute ischemic stroke. It has been suggested that thrombus length would influence functional outcome via interaction with the collateral circulation. We investigated the individual and combined effects of thrombus length assessed by the clot burden score and collateral status assessed by a FLAIR vascular hyperintensity–ASPECTS rating system on functional outcome (mRS). MATERIALS AND METHODS: Patients with anterior circulation acute ischemic stroke due to large-vessel occlusion from the ASTER and THRACE trials treated with endovascular thrombectomy were pooled. The clot burden score and FLAIR vascular hyperintensity score were determined on MR imaging obtained before endovascular thrombectomy. Favorable outcome was defined as an mRS score of 0–2 at 90 days. Association of the clot burden score and the FLAIR vascular hyperintensity score with favorable outcome (individual effect and interaction) was examined using logistic regression models. RESULTS: Of the 326 patients treated by endovascular thrombectomy with both the clot burden score and FLAIR vascular hyperintensity assessment, favorable outcome was observed in 165 (51%). The rate of favorable outcome increased with clot burden score (smaller clots) and FLAIR vascular hyperintensity (better collaterals) values. The association between clot burden score and functional outcome was significantly modified by the FLAIR vascular hyperintensity score, and this association was stronger in patients with good collaterals, with an adjusted OR = 6.15 (95% CI, 1.03–36.81). CONCLUSIONS: The association between the clot burden score and functional outcome varied for different collateral scores. The FLAIR vascular hyperintensity score might be a valuable prognostic factor, especially when contrast-based vascular imaging is not available.
- 1 February 2020
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 47 (1) , 5-12
Comparison between postmortem computed tomography and autopsy in the detection of traumatic head injuries
- 1 February 2020
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 47 (1) , 5-12
Comparison between postmortem computed tomography and autopsy in the detection of traumatic head injuries
- 15 October 2019
- Published by Wolters Kluwer Health in Neurology
- Vol. 93 (16) , e1498-e1506
White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy
Introduction To determine the influence of white matter hyperintensity (WMH) burden on functional outcome, rate of symptomatic intracerebral hemorrhage (sICH), and procedural success in patients with acute ischemic stroke (AIS) treated by mechanical thrombectomy (MT) with current stentriever/aspiration devices. Methods Patients with AIS due to large vessel occlusion (LVO) from the Thrombectomie des Artères Cérébrales (THRACE) trial and prospective cohorts from 2 academic comprehensive stroke centers treated with MT were pooled and retrospectively analyzed. WMH volumes were obtained by semiautomated planimetric segmentation and tested in association with the rate of favorable outcome (90-day functional independence), substantial recanalization after MT, and sICH. Results A total of 496 participants were included between 2015 and 2018 (50% female, mean age 68.1 ± 15.0 years). Overall, 434 (88%) patients presented with detectable WMH (mean ± SD 4.93 ± 7.7). Patients demonstrated increasingly worse outcomes with increasing WMH volumes (odds ratio [aOR]1.05 per 1-cm3 increase for unfavorable outcome, 95% confidence interval [CI] 1.01–1.06, p = 0.014). Fifty-seven percent of patients in the first quartile of WMH volume vs 28% in the fourth quartile demonstrated favorable outcome (p < 0.001). WMH severity was not associated with sICH rate (aOR 0.99, 95% CI 0.93–1.04, p = 0.66), nor did it influence recanalization success (aOR 0.99, 95% CI 0.96–1.02, p = 0.84). Conclusion Our study provides evidence that in patients with AIS due to LVO and high burden of WMH as assessed by pretreatment MRI, the safety and efficacy profiles of MT are similar to those in patients with lower WMH burden and confirms that they are at higher risk of unfavorable outcome. Because more than a quarter of patients in the highest WMH quartile experienced favorable 3 months outcome, WMH burden may not be a good argument to deny MT. ClinicalTrials.gov Identifier NCT01062698.
- 15 October 2019
- Published by Wolters Kluwer Health in Neurology
- Vol. 93 (16) , e1498-e1506
White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy
Introduction To determine the influence of white matter hyperintensity (WMH) burden on functional outcome, rate of symptomatic intracerebral hemorrhage (sICH), and procedural success in patients with acute ischemic stroke (AIS) treated by mechanical thrombectomy (MT) with current stentriever/aspiration devices. Methods Patients with AIS due to large vessel occlusion (LVO) from the Thrombectomie des Artères Cérébrales (THRACE) trial and prospective cohorts from 2 academic comprehensive stroke centers treated with MT were pooled and retrospectively analyzed. WMH volumes were obtained by semiautomated planimetric segmentation and tested in association with the rate of favorable outcome (90-day functional independence), substantial recanalization after MT, and sICH. Results A total of 496 participants were included between 2015 and 2018 (50% female, mean age 68.1 ± 15.0 years). Overall, 434 (88%) patients presented with detectable WMH (mean ± SD 4.93 ± 7.7). Patients demonstrated increasingly worse outcomes with increasing WMH volumes (odds ratio [aOR]1.05 per 1-cm3 increase for unfavorable outcome, 95% confidence interval [CI] 1.01–1.06, p = 0.014). Fifty-seven percent of patients in the first quartile of WMH volume vs 28% in the fourth quartile demonstrated favorable outcome (p < 0.001). WMH severity was not associated with sICH rate (aOR 0.99, 95% CI 0.93–1.04, p = 0.66), nor did it influence recanalization success (aOR 0.99, 95% CI 0.96–1.02, p = 0.84). Conclusion Our study provides evidence that in patients with AIS due to LVO and high burden of WMH as assessed by pretreatment MRI, the safety and efficacy profiles of MT are similar to those in patients with lower WMH burden and confirms that they are at higher risk of unfavorable outcome. Because more than a quarter of patients in the highest WMH quartile experienced favorable 3 months outcome, WMH burden may not be a good argument to deny MT. ClinicalTrials.gov Identifier NCT01062698.
- 15 May 2019
- Published by Morressier GmbH
1 - WHITE MATTER HYPER-INTENSITY BURDEN AND OUTCOME IN ISCHEMIC STROKE PATIENTS TREATED WITH MECHANICAL THROMBECTOMY: FINDINGS FROM THE THRACE TRIAL AND MULTICENTER STUDY
Introduction: We aimed to determine the influence of WMH burden on functional outcome, rate of symptomatic intracranial hemorrhage (ICH) and procedural success in AIS patients treated by MT with current stentriever/aspiration devices. Patients and Methods: Patients with AIS due to LVO from THRACE trial, and prospective cohorts from two academic comprehensive stroke centers
- 15 May 2019
- Published by Morressier GmbH
1 - WHITE MATTER HYPER-INTENSITY BURDEN AND OUTCOME IN ISCHEMIC STROKE PATIENTS TREATED WITH MECHANICAL THROMBECTOMY: FINDINGS FROM THE THRACE TRIAL AND MULTICENTER STUDY
Introduction: We aimed to determine the influence of WMH burden on functional outcome, rate of symptomatic intracranial hemorrhage (ICH) and procedural success in AIS patients treated by MT with current stentriever/aspiration devices. Patients and Methods: Patients with AIS due to LVO from THRACE trial, and prospective cohorts from two academic comprehensive stroke centers
- 12 November 2018
- Published by Springer Nature in European Radiology
- Vol. 29 (5) , 2624-2631
Validation of overestimation ratio and TL-SVS as imaging biomarker of cardioembolic stroke and time from onset to MRI
We aimed to determine in the “THRACE” trial, the clinical and MRI technical parameters associated with the two-layered susceptibility vessel sign (TL-SVS) and the overestimation ratio (overR).
- 12 November 2018
- Published by Springer Nature in European Radiology
- Vol. 29 (5) , 2624-2631
Validation of overestimation ratio and TL-SVS as imaging biomarker of cardioembolic stroke and time from onset to MRI
We aimed to determine in the “THRACE” trial, the clinical and MRI technical parameters associated with the two-layered susceptibility vessel sign (TL-SVS) and the overestimation ratio (overR).